<< Back to Results
14T-MC-JVBB - A Randomized, Double-Blind, Multicenter Phase 3 Study of Irinotecan, Folinic Acid, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab or Placebo in Patients with Metastatic, Colorectal Carcinoma Progressive or Following First-Line Combination Therapy with Bevacizumab, Oxaliplatin, and a Fluoropyrimidine. Accrual limited to Abington Cancer Care Specialists.
Clinical Trial Categories
- The Rosenfeld Cancer Center at 215-481-2402
- The Rosenfeld Cancer Center